Jan 06, 2020 - Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Dec 21, 2019 - But the big biotech isn't a happy camper about its contribution.
Dec 19, 2019 - AbbVie's (ABBV) oral JAK inhibitor, upadacitinib, receives approval in Europe for treating rheumatoid arthritis under the trade name of Rinvoq.
Dec 18, 2019 - The biotech sector was in focus this week with pipeline and regulatory updates from quite a few players.
Dec 18, 2019 - The Zacks Analyst Blog Highlights: Apple, Cisco Systems, Oracle, HSBC and Amgen
Dec 17, 2019 - Top Analyst Reports for Apple, Cisco & Oracle
Dec 13, 2019 - Biotech can be a risky sector for those interested in healthcare stocks, but Amgen has found a way to manage the risk and reap the rewards.
Dec 11, 2019 - The biotech sector witnesses pipeline updates from the annual ASH meet.
Dec 10, 2019 - Following the new deals in the healthcare space, a few biotech ETFs hit new highs.
Dec 10, 2019 - Healthpeak's (PEAK) lease amendment and extension with Amgen at the Britannia Oyster Point of the former offers flexibility in addressing lease-expiration issue at this property.